Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab

N/ACompletedNCT07015333

Commonwealth Healthcare Corporation31 enrolled

Overview

Chart review of records of patients treated for betel nut-induced oral cancer with pembrolizumab and cetuximab.

Study Type

OBSERVATIONAL

Enrollment

Treatment of betel nut-induced oral cancer with pembrolizumab and cetuximab

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Advanced betel nut-induced oral cancer Exclusion Criteria: * None

CHCC

Saipan, MP, Northern Mariana Islands

Objective Response Rate (ORR)

Assessed by clinical measurement of largest tumor size

Time frame: From date first treatment received until 3 months later

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.